Boehringer Ingelheim announced the official completion of its newly established R&D center in Zhangjiang, Shanghai, marking a new phase in...
-
-
Recent Updates
- Chinese Car Exports Surge Amid Domestic Sales Decline
- Boehringer Ingelheim Establishes R&D Center in Shanghai, Enhances Early Clinical Development of New Drugs, Deepens External Innovation Collaboration
- China-EU Deal Restricts $7.5 Billion Chinese Hybrid Export Surge
- EU Pact with China to Cut Hybrid Car Exports, Tariffs in Bid to Rebalance Trade Deficit
- China’s Stringent Safety Regulations Impose New Limits on Vehicle Technologies
- China’s Coking Coal Purchase Costs Surge, Imports Saw Declines in Recent Data
- China’s Robotic Advances and the Future of AI
- China’s AI-Led Industrial Revolution Sparks Manufacturing Growth
- Volkswagen CEO Endorses EU’s Initiative to Counter China’s Dominance
- Chinese Auto Industry in Turbulence: Local Sales Slump, Export Revenues Climb
Blogroll